Annelien Bredenoord

Annelien Bredenoord is a professor of Ethics of Biomedical Innovation at the University Medical Center Utrecht. Her research, consultancy and teaching is focused on the ethical issues in emerging biomedical technology and translational medicine. She is particularly fascinated by the rapid developments in genetics/genomics, regenerative medicine, stem cell research, biobanking, surgical innovation, Big Data and the associated ethical and societal challenges: how to translate biomedical innovations from basic research into clinical care and society in an ethically sound way?

She published widely in those fields and is member of several (inter)national committees among which the Ethics Committee of the International Society for Stem Cell Research (ISSCR), The Young Academy of the Royal Netherlands Academy of Arts and Sciences (KNAW), The Young Health Council, The National Indication Committee Preimplantation Genetic Diagnosis, The NIAS Lorenz Advisory Board, L 'Oreal UNESCO For Women in Science program, and UMC Utrecht’s Research Ethics Committee (METC).

Annelien Bredenoord

abredeno@umcutrecht.nl

Areas of Expertise

Ethics

Our ultimate goal is that people live healthily for longer

Our ultimate goal is that people live healthily for longer

We know far less about the exposome than we do about the human genome. So far, we only understand about half of the disease burden for which we know the environment plays a role. If we want to prevent people from becoming ill, then we need to understand the other half too. We therefore want to systematically analyse the exposome for the first time. We will start with research into the causes of cardiovascular disease and type 2 diabetes. The techniques and insights from this research will also be applicable to other chronic conditions.

Read More
LinkedinYouTube